Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Gurunanda Pain Relief

Last content change checked dailysee data sync status

Active ingredient
Lidocaine Hydrochloride 40 mg/1 mL
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2025
Label revision date
November 10, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Lidocaine Hydrochloride 40 mg/1 mL
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2025
Label revision date
November 10, 2025
Manufacturer
GuruNanda, LLC.
Registration number
M017
NDC root
70708-101
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You may find this medication helpful for the temporary relief of pain. While specific details about how it works are not provided, it is designed to provide you with comfort when experiencing discomfort. Please note that this product will be available starting July 1, 2025, so keep an eye out for it if you think it could be beneficial for you.

Uses

You can use this medication for the temporary relief of pain. It is designed to help alleviate discomfort, making it easier for you to go about your daily activities.

Additionally, there are no concerns regarding teratogenic effects (which means it does not cause birth defects) or nonteratogenic effects associated with this medication. This makes it a safer option for those who may be worried about potential risks.

Dosage and Administration

If you are 12 years old or older, you can apply this medication to the affected area up to 3 to 4 times a day. Make sure to follow this guideline to ensure safe and effective use.

If you have a child under 12, it's important not to use this medication without first consulting a doctor. Always prioritize safety and seek professional advice when it comes to younger patients.

What to Avoid

You should avoid using this product in large quantities, especially on raw or blistered skin, and never apply it to wounds or damaged areas. If you have an allergy to any of the ingredients, do not use it. While using this product, be careful to keep it away from your eyes and mucous membranes, and do not apply it to irritated skin or if you experience excessive irritation.

Additionally, avoid spraying it on your face, inhaling the spray, or applying it to skin folds. Do not use a heating pad or bandage on the treated area, and refrain from using it alongside other topical pain relievers. Following these guidelines will help ensure your safety and the effectiveness of the product.

Side Effects

When using this product, it's important to apply it only as directed and avoid contact with your eyes and mucous membranes. You should not use it on wounds, damaged skin, or in large quantities, especially over raw surfaces or blistered areas. If you have sensitive skin or kidney problems, consult your doctor before use.

Be aware of potential adverse reactions. If your condition worsens, symptoms last more than 7 days, or if you notice pain, swelling, or blistering at the application site, stop using the product and seek medical advice. Additionally, if you are pregnant or breastfeeding, it's best to consult a healthcare professional before using this product. If swallowed, seek immediate medical help or contact a Poison Control Center.

Warnings and Precautions

This product is for external use only, so please avoid using it on wounds, damaged skin, or in large quantities, especially over raw surfaces or blistered areas. If you have sensitive skin or kidney problems, consult your doctor before using it. Always follow the instructions on the label carefully, and avoid contact with your eyes and mucous membranes. Do not apply it to irritated skin, and refrain from using it with heating pads or other topical pain relievers.

If you notice that your condition worsens, symptoms last longer than 7 days, or if you see signs of skin injury like pain, swelling, or blistering where you applied the product, stop using it and contact your doctor. Keep this product out of reach of children, and if swallowed, seek medical help or call Poison Control at 1-800-222-1222 immediately.

Overdose

If you or someone else has swallowed too much of this medication, it’s important to seek medical help right away. You can contact a Poison Control Center at 1-800-222-1222 for immediate assistance.

Signs of an overdose may include unusual symptoms, but specific details about these symptoms are not provided here. If you notice anything concerning, don’t hesitate to get help. Remember, acting quickly can make a significant difference in ensuring safety and health.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

If your child is under 12 years old, it's important not to use this medication without first consulting a doctor. For those aged 12 and older, you can apply the medication to the affected area, but be sure to limit it to no more than 3 to 4 times a day. Always follow your healthcare provider's advice to ensure safe and effective use.

Geriatric Use

If you are an older adult or caring for one, it's important to consult with a doctor before using this medication, especially if you have sensitive skin or any kidney problems. Kidney problems can affect how your body processes medications, so your doctor may need to adjust the dosage or monitor you more closely. Always prioritize safety and communication with your healthcare provider to ensure the best care.

Renal Impairment

If you have kidney problems, it's important to consult your doctor before using this medication. Your healthcare provider can help determine if it's safe for you and may suggest adjustments to your dosage or monitoring based on your specific condition. Always prioritize your health by seeking professional advice when it comes to medications and kidney issues.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (issues with liver function).

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver health and medication use. They can help ensure that you receive the safest and most effective treatment.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you. Always share your complete list of medications and any health conditions you have to receive the best care possible.

Storage and Handling

To ensure the safety and effectiveness of your product, always check that the printed seal is intact before use; do not use it if the seal is broken or missing. For proper storage, keep the product in a cool, dry place, away from direct sunlight and excessive moisture. This will help maintain its quality and prevent any degradation.

Additional Information

No further information is available.

FAQ

What is the primary use of this drug?

This drug is used for the temporary relief of pain.

Who can use this product?

Adults and children 12 years of age and older can apply it to the affected area not more than 3 to 4 times daily. Children under 12 years of age should not use it and should consult a doctor.

What should I avoid while using this product?

You should avoid contact with eyes and mucous membranes, applying it to irritated skin, and using it at the same time as other topical analgesics.

What are the warnings associated with this product?

This product is for external use only. Do not use it in large quantities, on wounds or damaged skin, or if you are allergic to any of its ingredients.

What should I do if I experience adverse reactions?

Stop use and ask a doctor if your condition worsens, symptoms persist for more than 7 days, or you notice signs of skin injury like pain or swelling.

Is it safe to use this product during pregnancy or breastfeeding?

If you are pregnant or breastfeeding, you should ask a health professional before using this product.

What should I do if the product is swallowed?

If swallowed, get medical help or contact a Poison Control Center immediately at 1-800-222-1222.

How should I store this product?

Store the product in a cool, dry place, away from direct sunlight and excessive moisture.

Packaging Info

Below are the non-prescription pack sizes of Gurunanda Pain Relief (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Gurunanda Pain Relief.
Details

Drug Information (PDF)

This file contains official product information for Gurunanda Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of pain.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children aged 12 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is limited to the specified frequency to avoid potential adverse effects.

For children under 12 years of age, the product is not recommended for use. Healthcare professionals should advise caregivers to consult a doctor for appropriate alternatives or guidance.

Contraindications

Use of this product is contraindicated in the following situations:

  • Application in large quantities, particularly over raw surfaces or blistered areas, is not recommended due to the potential for increased irritation and adverse effects.

  • The product should not be applied to wounds or damaged skin, as this may exacerbate injury or lead to infection.

  • Concurrent use with heating pads is contraindicated, as this may enhance absorption and increase the risk of systemic effects.

  • Individuals with known allergies to any ingredients in this product should avoid its use to prevent allergic reactions.

Additionally, while using this product, the following precautions must be observed:

  • Avoid contact with eyes and mucous membranes to prevent irritation.

  • Do not apply to irritated skin or if excessive irritation develops, as this may worsen the condition.

  • Spraying on the face is not advised to minimize the risk of adverse reactions.

  • Inhalation of the spray should be avoided to prevent respiratory irritation.

  • Application to skin folds is contraindicated due to the risk of trapping moisture and increasing irritation.

  • Bandaging or applying local heat, including heating pads or medicated patches, to the area of use is not permitted to avoid enhanced absorption and potential side effects.

  • The product should not be used simultaneously with other topical analgesics to prevent additive effects and potential toxicity.

Warnings and Precautions

For external use only. This product should not be applied in large quantities, particularly over raw surfaces or blistered areas, nor should it be used on wounds or damaged skin. The application of this product in conjunction with a heating pad is contraindicated. Individuals with known allergies to any ingredients in this formulation should refrain from use.

Prior to using this product, it is advisable for individuals with sensitive skin or kidney problems to consult a healthcare professional.

When utilizing this product, it is imperative to adhere strictly to the provided directions and warnings. Users should avoid contact with the eyes and mucous membranes, and the product should not be applied to irritated skin or if excessive irritation develops. Spraying on the face and inhalation of the spray should be avoided. Additionally, application to skin folds is discouraged. Bandaging or applying local heat, such as heating pads or medicated patches, to the area of use is not recommended. Concurrent use with other topical analgesics is also contraindicated.

Users should discontinue use and seek medical advice if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Signs of skin injury, such as pain, swelling, or blistering at the application site, warrant immediate consultation with a healthcare provider.

This product should be kept out of reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact a Poison Control Center at 1-800-222-1222.

Side Effects

Patients using this product may experience a range of adverse reactions, which can be categorized based on seriousness and frequency.

Warnings indicate that the product is for external use only. It should not be used in large quantities, particularly over raw surfaces or blistered areas, on wounds or damaged skin, or in conjunction with a heating pad. Patients who are allergic to any ingredients in the product should avoid its use.

Before using this product, patients should consult a doctor if they have sensitive skin or kidney problems. During use, it is crucial to adhere strictly to the directions and warnings provided on the label. Patients should avoid contact with eyes and mucous membranes, and should not apply the product to irritated skin or if excessive irritation develops. Additionally, patients should refrain from spraying the product on the face, inhaling the spray, or applying it to skin folds. Bandaging or applying local heat, such as heating pads or medicated patches, to the area of use is also not recommended. Concurrent use with other topical analgesics should be avoided.

Patients are advised to stop use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Signs of skin injury, such as pain, swelling, or blistering at the application site, should prompt immediate medical consultation.

Additional considerations include the recommendation for pregnant or breastfeeding patients to seek advice from a health professional before use. In the event of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Gurunanda Pain Relief (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Gurunanda Pain Relief.
Details

Pediatric Use

Pediatric patients under 12 years of age should not use this medication. Consultation with a healthcare professional is advised for this age group. For adolescents aged 12 years and older, the recommended application is to the affected area not more than 3 to 4 times daily.

Geriatric Use

Elderly patients should consult a healthcare provider prior to using this medication, particularly if they have sensitive skin or pre-existing kidney problems. It is essential to assess the individual health status of geriatric patients, as these factors may influence the safety and efficacy of the treatment. Monitoring for adverse effects and potential complications is advised in this population to ensure optimal therapeutic outcomes.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use, as reduced kidney function may affect the safety and efficacy of the treatment. It is essential to assess renal function and consider potential dosing adjustments or monitoring requirements based on individual patient circumstances.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance on managing the situation.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

If pregnant or breast-feeding, it is advised to consult a health professional prior to use. No specific non-teratogenic effects have been identified. Additionally, there are no detailed findings related to nonclinical toxicology or animal pharmacology and toxicology available.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 if the product is swallowed. It is essential for patients to use the product only as directed and to read and follow all directions and warnings provided on the label.

Patients should be cautioned to avoid contact with their eyes and mucous membranes, as well as to refrain from applying the product to irritated skin or if excessive irritation develops. It is important to instruct patients to avoid spraying the product on their face and to prevent inhalation of the spray.

Additionally, patients should be informed not to apply the product to skin folds and to avoid bandaging or applying local heat, such as heating pads or medicated patches, to the area of use. They should also be advised against using the product simultaneously with other topical analgesics.

Finally, healthcare providers should encourage patients to consult a doctor before use if they have sensitive skin or any kidney problems.

Storage and Handling

The product is supplied in packaging that ensures integrity and safety. It is imperative that the product is not used if the printed seal is broken or missing, as this may compromise its quality and efficacy.

For optimal storage conditions, the product should be kept in a cool, dry place, away from direct sunlight and excessive moisture. These conditions are essential to maintain the product's stability and effectiveness throughout its shelf life.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Gurunanda Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Gurunanda Pain Relief, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.